ARCHIVES

Toxic Substance Act Would Affect Cancer Program

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

NCI May Support More Training Of Cancer Surgeons

May 23, 1975

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000

Fy 1981 Budget Breakdown B Mechanism, Activity

February 1, 1980

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

January 20, 2006